Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Kleinermans

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane Kleinermans
Pharmacology Research & Perspectives|May 8, 2022
An open-label randomized study of the relative absorption of gastro-resistant risedronate taken fasted or with food versus immediate-release risedronateDiane Kleinermans, Andrew Joyson, Heather Wray
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole potentiates warfarin-induced prothrombin time prolongationLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole does not affect the steady-state pharmacokinetics of digoxinLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazoleLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteersLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Effect of food on the pharmacokinetics of multiple-dose oral voriconazoleLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteersLynn Purkins, Nolan Wood, Parviz Ghahramani, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Effect of omeprazole on the steady-state pharmacokinetics of voriconazoleNolan Wood, Keith Tan, Lynn Purkins, et al.
Fundamental & Clinical Pharmacology|March 21, 2002
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteersStéphane Schück, Danièle Bentué-Ferrer, Diane Kleinermans, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane Kleinermans
Pharmacology Research & Perspectives|May 8, 2022
An open-label randomized study of the relative absorption of gastro-resistant risedronate taken fasted or with food versus immediate-release risedronateDiane Kleinermans, Andrew Joyson, Heather Wray
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole potentiates warfarin-induced prothrombin time prolongationLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole does not affect the steady-state pharmacokinetics of digoxinLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazoleLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteersLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Effect of food on the pharmacokinetics of multiple-dose oral voriconazoleLynn Purkins, Nolan Wood, Diane Kleinermans, et al.
British Journal of Clinical Pharmacology|November 18, 2003
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteersLynn Purkins, Nolan Wood, Parviz Ghahramani, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Effect of omeprazole on the steady-state pharmacokinetics of voriconazoleNolan Wood, Keith Tan, Lynn Purkins, et al.
Fundamental & Clinical Pharmacology|March 21, 2002
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteersStéphane Schück, Danièle Bentué-Ferrer, Diane Kleinermans, et al.
Pageof 2